跳至主導覽
跳至搜尋
跳過主要內容
澳門理工大學 首頁
English
中文
在 澳門理工大學 搜尋內容
首頁
研究單位
研究成果
學術履歷
新聞/媒體
連絡專家
查看斯高帕斯 (Scopus) 概要
郎 斌
Associate Professor
Associate Professor
,
Peking University Health Science Center - Macao Polytechnic University Nursing Academy
電話
8893 6952 / 8599 3440
電子郵件
blang
mpu.edu
mo
h-index
1351
引文
23
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
2005
2024
每年研究成果
概覽
指紋
網路
研究成果
(51)
新聞/媒體
(2)
類似的個人檔案
(1)
指紋
查看啟用 BIN LANG 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Biochemistry, Genetics and Molecular Biology
Cancer Cell
47%
Long Non-Coding RNA
31%
Tumor Suppressor Protein
23%
Wart Virus
19%
MicroRNA
19%
Osteoblast
19%
CRISPR/Cas9
19%
Promoter Region
15%
Cell Growth
15%
Genomics
14%
Carcinogenesis
13%
Genome Editing
13%
Molecular Mechanism
12%
Oncogene
11%
Cisplatin
9%
CD44
9%
P53 Upregulated Modulator of Apoptosis
9%
Saos-2 Cells
9%
Epidermal Growth Factor Receptor
9%
Leucine-Rich Repeat
9%
Immunoglobulin Domain
9%
PTENP1
9%
DNA Methyltransferase
9%
Transcription
9%
Angiogenesis
9%
TATA Box
9%
GA Binding Protein
9%
Immune Evasion
9%
Karyopherin
9%
KLF4
9%
Differentially Expressed Gene
9%
Green Fluorescent Protein
9%
Importin
9%
Endonuclease
9%
Cas12a
9%
Gene Therapy
9%
CD133
9%
PRKACA
9%
Mutagenic Activity
9%
Zinc Finger Nuclease
9%
Immunoreactivity
8%
Luciferase
7%
Programmed Cell Death
6%
Messenger RNA
6%
Real-Time Polymerase Chain Reaction
6%
Methylation
6%
CRISPR
5%
Mesenchymal-Epithelial Transition
5%
Cortisol
5%
Transcription Factors
5%
Pharmacology, Toxicology and Pharmaceutical Science
Bladder Cancer
100%
microRNA 34a
39%
Cancer Growth
20%
Renal Cell Carcinoma
19%
Fibulin
19%
Immunoglobulin
19%
Leucine
19%
microRNA 221
19%
Malignant Neoplasm
17%
PUMA Protein
11%
Drug Resistance
9%
Bladder Carcinoma
9%
Secretase
9%
Recurrent Disease
9%
Kruppel Like Factor 4
9%
Rosiglitazone
9%
microRNA
9%
Cisplatin
9%
Epidermal Growth Factor Receptor
9%
Cancer Recurrence
9%
Chemotherapy Regimen
9%
Western Blot
8%
Messenger RNA
7%
Muscle Invasive Bladder Cancer
7%
Luciferase
6%
Neoplasm
5%
Medicine and Dentistry
Adrenalectomy
51%
Pyeloplasty
29%
Pheochromocytoma
22%
Cancer Cell
19%
Bladder Cancer
19%
Chemotherapy
19%
Bleeding
16%
Pelvis
10%
Programmed Cell Death
10%
Primary Hyperaldosteronism
9%
microRNA 34a
9%
Ureteropelvic Junction Obstruction
9%
Adenoma
9%
Adrenal Tumor
9%
Hepatocyte Growth Factor
9%
5637 Cell Line
9%
Cisplatin
9%
Adrenal Cyst
9%
Clear Cell Renal Cell Carcinoma
9%
Promoter Region
9%
Karyopherin
9%
microRNA 221
9%
Osteoblast
9%
Obstruction
9%
Fibulin
9%
Open Surgery
8%
Neoplasm
8%
Fascia
7%
Genetic Transfection
7%
Hydrocortisone
7%
Postoperative Complication
6%
Peroperative Complication
6%
Surgical Anastomosis
5%
Conversion to Open Surgery
5%
Aldosterone
5%